Sophiris Bio, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2015. For the quarter, the company reported a net loss of $3.7 million or $0.22 per share compared to a net loss of $8.2 million or $0.49 per share for the three months ended September 30, 2014.

For nine months, the company reported a net loss of $11.7 million or $0.69 per share compared to a net loss of $25.4 million or $1.54 per share for the nine months ended September 30, 2014.